Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. (Q45936373)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 June 2013

Language	Label	Description	Also known as
English	Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.	scientific article published on 13 June 2013

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

1 reference

based on heuristic

inferred from title

author name string

Ang Huang

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

Bo Zhang

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

Bo Wang

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

Fan Zhang

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

Ke-Xing Fan

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

Ya-Jun Guo

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

publication date

13 June 2013

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

62

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

9

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

1439-1451

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

https://scigraph.springernature.com/pub.10.1007/s00262-013-1450-6

0 references

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Immunotherapy for non-small cell lung cancer: novel approaches to improve patient outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition)

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

MHC II lung cancer vaccines prime and boost tumor-specific CD4+ T cells that cross-react with multiple histologic subtypes of nonsmall cell lung cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Tumor escape mechanism governed by myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Myeloid suppressor cell depletion augments antitumor activity in lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

CD14(+)S100A9(+) monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Immunosuppressive activity of CD14+ HLA-DR- cells in squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

The 2004 World Health Organization classification of lung tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Expression of NADPH oxidase in human pancreatic islets.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

The CD14+ CD16+ blood monocytes: their role in infection and inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

S100A9 a new marker for monocytic human myeloid-derived suppressor cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Tumor-induced myeloid-derived suppressor cell function is independent of IFN-γ and IL-4Rα.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

HaCaT Keratinocytes Overexpressing the S100 Proteins S100A8 and S100A9 Show Increased NADPH Oxidase and NF-κB Activities

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1450-6

21 January 2018

Identifiers

10.1007/S00262-013-1450-6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/23760662

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45936373&oldid=1189720571"